Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Chemotherapy for osteosarcoma with high-dose methotrexate is effective and outpatient therapy is now possible

Nature Clinical Practice Oncology volume 4, pages 624–625 (2007)Cite this article

boxed-textLe Deley MC et al. (2007) SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients. Eur J Cancer 43: 752–761

Background

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Meyers PA et al. (2005) Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol 23: 2004–2011

    Article  CAS  Google Scholar 

  2. Whelan J et al. (2006) Management of osteosarcoma. Curr Treat Options Oncol 7: 444–455

    Article  Google Scholar 

  3. Laginha KM et al. (2005) Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors. Clin Cancer Res 11: 6944–6949

    Article  CAS  Google Scholar 

  4. Lewis M et al. (2007) Hearing loss in children with osteosarcoma [abstract #9517]. J Clin Oncol 25

  5. Anderson PM and Pearson M (2006) Novel therapeutic approaches in pediatric and young adult sarcomas. Curr Oncol Rep 8: 310–315

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by James Casey, Editorial Assistant, Nature Clinical Practice.

Author information

Author notes

  1. University of Texas MD Anderson Cancer Center, Unit 87, 1515 Holcombe Boulevard, Houston, TX 77030–4009, USA pmanders@mdanderson.org

Authors and Affiliations

  1. P Anderson is a Professor of Pediatrics at the University of Texas MD Anderson Cancer Center, Houston, TX, USA.,

    Pete Anderson

Authors
  1. Pete Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anderson, P. Chemotherapy for osteosarcoma with high-dose methotrexate is effective and outpatient therapy is now possible. Nat Rev Clin Oncol 4, 624–625 (2007). https://doi.org/10.1038/ncponc0953

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0953

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing